Can malabsorption night blindness affect only one eye?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Malabsorption-Related Night Blindness Does Not Affect Only One Eye

No, malabsorption-related night blindness from vitamin A deficiency is a bilateral (both eyes) condition, not unilateral. Vitamin A deficiency affects the entire body's vitamin A stores and impacts both retinas equally, causing symmetric bilateral visual dysfunction 1, 2.

Why Night Blindness from Malabsorption is Bilateral

Vitamin A deficiency from malabsorption is a systemic nutritional deficiency that affects both eyes simultaneously because:

  • Serum retinol (vitamin A) circulates throughout the body and supplies both retinas equally 2, 3
  • Rhodopsin synthesis, which is essential for rod photoreceptor function and night vision, becomes impaired bilaterally when vitamin A stores are depleted 2, 3
  • The pathophysiology involves insufficient substrate for visual pigment regeneration in both eyes, not a localized ocular problem 1, 4

Clinical Presentation Pattern

Night blindness (nyctalopia) presents as the earliest symptom of vitamin A deficiency and affects both eyes 2, 5:

  • Patients report progressive bilateral difficulty seeing in dim lighting or at night 5, 6
  • Dark adaptation becomes impaired in both eyes, typically reduced by 1-2.5 log units bilaterally 3
  • Electroretinogram (ERG) testing demonstrates bilateral scotopic (rod) response abnormalities, ranging from reduced oscillatory potentials to completely extinguished rod responses 5, 3, 6

Important Clinical Pitfall

If a patient presents with unilateral night blindness, vitamin A deficiency from malabsorption is NOT the diagnosis—look for other causes 1:

  • Unilateral night vision loss suggests localized ocular pathology (retinal disease, optic nerve disease) or neurological conditions, not nutritional deficiency 1
  • Cancer-associated retinopathy (CAR) can mimic vitamin A deficiency but may present asymmetrically and should be considered in patients with malignancy 4
  • True vitamin A deficiency always produces bilateral symmetric findings on examination and ERG testing 3, 6

High-Risk Populations for Malabsorption

Patients at highest risk for developing bilateral night blindness from vitamin A malabsorption include 2, 5:

  • Post-bariatric surgery patients, especially after malabsorptive procedures (BPD/DS, RYGB) 1, 5
  • Short bowel syndrome from intestinal resections 2, 5, 6
  • Cystic fibrosis patients 2, 5
  • Chronic liver disease and hepatopathy 2, 5
  • Patients on octreotide treatment 5
  • Crohn's disease with multiple bowel resections 6

Diagnostic Approach When Night Blindness is Reported

When evaluating night blindness in at-risk patients, obtain bilateral assessment 1, 5:

  • Check serum vitamin A levels (normal range 400-700 ng/ml or 20-120 µg/dL) 1, 4, 6
  • Perform bilateral dark adaptation testing 3, 6
  • Obtain full-field electroretinogram showing bilateral scotopic responses 5, 6
  • Document visual acuity in both eyes (often remains normal initially, typically 20/20 to 20/40) 5

Treatment Restores Bilateral Function

Vitamin A supplementation reverses night blindness bilaterally when initiated promptly 7, 3:

  • Adults with deficiency: 10,000-25,000 IU oral vitamin A daily for 1-2 weeks 7
  • Night vision improvement occurs within 7 days of treatment in both eyes 4
  • ERG normalization and dark adaptation recovery occur bilaterally over weeks to months 3, 4
  • Recheck vitamin A levels at 3 months after treatment 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Vitamin A Deficiency Due to Malabsorption

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Night blindness and Crohn's disease.

International ophthalmology, 2014

Guideline

Vitamin A Repletion Dosing Regimen

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

Is well-formed, normal-colored stool with no other abdominal symptoms and night blindness indicative of malabsorption with no other symptoms?
What could be causing night blindness, difficulty with vision, back pain, and recent diarrhea in a 15-year-old female with a history of night blindness since childhood?
What are the symptoms of vitamin A deficiency due to malabsorption beyond night blindness?
Is worsening vision at dusk a sign of aging or a symptom of malabsorption in a 41-year-old female?
What is the recommended protocol for IV vitamin therapy in patients with general wellness or mild deficiencies?
Can a capsule endoscopy be used to diagnose an elderly patient with diarrhea, abdominal cramping, and hematochezia who prefers to avoid a colonoscopy?
What is the difference between escitalopram (Lexapro) and citalopram (Celexa) in terms of efficacy and side effects?
What is the recommended treatment duration for Zerbaxa (ceftolozane/tazobactam) in hospital-acquired pneumonia (HAP) caused by Pseudomonas fluorescens according to Infectious Diseases Society of America (IDSA) guidelines?
What are the initial steps to manage a hamstring strain?
Can a capsule endoscopy be used to diagnose an elderly patient with diarrhea, abdominal cramping, and hematochezia who prefers to avoid a colonoscopy?
Is medical necessity met for percutaneous implantation of neurostimulator electrode array, epidural (63650 x(2)) and implantable neurostimulator (L8680 x(16)) for a patient with causalgia of the left lower limb (G57.72) and complex regional pain syndrome I of the right lower limb (G90.521)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.